Function Oncology utilizes a CRISPR-powered functional genomics platform to assess gene function in cancer patients, moving beyond traditional gene sequencing methods. This approach enables the identification of personalized therapeutic opportunities, enhancing the development of targeted cancer treatments.
Funding
$29.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

S3Founders
Product
Problem
Traditional gene sequencing methods often fall short in fully elucidating gene function within the complex tumor microenvironment of cancer patients. This limitation hinders the identification of truly personalized therapeutic opportunities and the development of effective, targeted cancer treatments.
Solution
Function Oncology leverages a CRISPR-powered functional genomics platform to directly assess gene function in patient-derived cancer cells. By moving beyond static gene sequencing, the platform dynamically measures the impact of individual gene perturbations on cancer cell behavior and drug sensitivity. This functional approach enables the identification of novel drug targets, prediction of patient response to specific therapies, and prioritization of personalized treatment strategies. The platform provides clinicians and pharmaceutical companies with actionable insights to optimize cancer treatment decisions and accelerate drug development.
Target Audience
The primary target audience includes oncologists, pharmaceutical companies, and clinical researchers involved in cancer drug development and personalized medicine.
Features
- CRISPR-based gene editing to systematically perturb gene function in cancer cells
- High-throughput screening assays to measure the impact of gene perturbations on cell viability, proliferation, and drug response
- Patient-derived xenograft (PDX) models to validate findings in vivo
- Proprietary algorithms to identify predictive biomarkers of drug sensitivity and resistance
- Cloud-based data analysis and visualization tools for easy interpretation of results
- Customizable reports for clinicians and pharmaceutical researchers